Chuen Yan Cheng
Prof Chuen Yan Cheng | |
|---|---|
| Born | June 18, 1954 |
| Nationality | American |
| Alma mater | Chinese University of Hong Kong (B.Sc.)
University of Newcastle, Australia (Ph.D.) |
| Known for | Male contraceptive drug |
| Awards | Richard E. Weizman Memorial Award Best Scientific Paper Award |
| Scientific career | |
| Fields | Biochemistry |
| Institutions | Rockefeller University |
Chuen Yan Cheng (Chinese: 鄭泉恩) is a Senior Scientist for the Population Council's Center for Biomedical Research. He is most well known as the inventor of the non-steroid male contraceptive drug——Adjudin,[1][2][3][4] which is the first male contraceptive drug on the market now finished clinical trials showing no side effects.[5][6]
Career
He graduated from the Chinese University of Hong Kong with a B.Sc. in 1977, and obtained his Ph.D. in biochemistry and cell biology at the University of Newcastle, Australia, in 1981. He came to New York as a Population Council post-doctoral trainee in 1981, studying in the laboratory of Drs. Wayne Bardin, Neal Musto, and Glen Gunsalus and was appointed as a research investigator in December 1982.
Cheng's research focuses on the development of a novel contraceptive for human males. These studies currently are supported by grants from the National Institutes of Health, the CONRAD Program, and the Andrew Mellon Foundation.
References
- ^ "Obsessed Scientist Finally Throttles 'Em! Non-Paternity Potion". The New York Observer. Archived from the original on 2008-09-24. Retrieved 2008-09-28.
- ^ "Future male "pill" targets testicles". Retrieved 2008-09-28.
- ^ "Male pill - Science Base". Retrieved 2008-09-28.
- ^ "Seed: The Hunt for Male Birth Control". Archived from the original on 2006-11-03. Retrieved 2008-09-28.
{{cite web}}: CS1 maint: unfit URL (link) - ^ "Trials for alternative male Pill show no side-effects". Retrieved 2008-09-28.
- ^ "Male Contraceptive Drug in the Works". Retrieved 2008-09-28.